Task force issues guidance for in vitro diagnostic device classification

09/19/2008 | FDAnews

The Global Harmonization Task Force's Study Group 1 has published its final guidance for classifying in vitro diagnostic medical devices. A four-tiered, risk-based system should be specifically designed for categorizing such products, according to the guidance.

View Full Article in:

FDAnews

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC